Dr. Faust is the Founder of NxGEN Vector Solutions, LLC. She has experience in scientific research, academic technology transfer, patent prosecution, and business development.

Dr. Faust received a B.S. in Microbiology from the Pennsylvania State University with Minors in Biochemistry and Molecular Biology, a Ph.D. in Cellular and Molecular Biology and a concurrent Master’s degree in Human Genetics from the University of Michigan. She held a postdoctoral position at the University of Pennsylvania studying the immune response to viral vectors used in gene therapy.

Dr. Faust is an inventor on multiple patent applications, including the recently issued U.S. Patent, No. 11,015,210, which further strengthens the Company’s intellectual property position and coverage for the Company’s CpG-depletion AAV Vector Technology. Dr. Faust has also received numerous awards for her work, including a Young Investigator Award from the American Transplant Congress and the Sanjeev Kumar Excellence in Science Award from the University of Pennsylvania.

Click to read about Our Technology

Dr. Rabinowitz is an inventor on multiple patent applications, including the recently issued U.S. Patent, No. 11,015,210, which further strengthens the Company’s intellectual property position and coverage for the Company’s CpG-depletion AAV Vector Technology.

Dr. Rabinowitz has extensive experience in AAV biology and expertise in increasing the transduction efficiency of viral gene delivery as well as AAV capsid development.

Dr. Rabinowitz received a B.S. in Biology from the University of Arizona and a Ph.D. in Genetics from Case Western Reserve University. He was a postdoctoral researcher at the University of North Carolina studying under the mentorship of R. Jude Samulski.

Dr Rabinowitz held professorships at Thomas Jefferson University and Temple University where he successfully ran academic laboratories concerned with AAV cardiac gene therapy before joining Pfizer as Senior Director of Capsid Development and Cardiac Gene Therapy.